Heavy	B:C0872279
Resistance	I:C0872279
Training	I:C0872279
in	O
Hypoxia	O
Enhances	O
1	O
RM	O
Squat	O
Performance	O
.	O

Heavy	O
Resistance	I:C0872279
Training	I:C0872279
in	O
Hypoxia	B:C0242184
Enhances	O
1	O
RM	O
Squat	O
Performance	O
.	O

Heavy	O
Resistance	I:C0872279
Training	I:C0872279
in	O
Hypoxia	O
Enhances	O
1	O
RM	O
Squat	B:C0241236
Performance	O
.	O

To	O
determine	O
if	O
heavy	B:C0872279
resistance	I:C0872279
training	I:C0872279
in	O
hypoxia	O
(	O
IHRT	O
)	O
is	O
more	O
effective	O
at	O
improving	O
strength	O
,	O
power	O
,	O
and	O
increasing	O
lean	O
mass	I:C0424678
than	O
the	O
same	O
training	O
in	O
normoxia	O
.	O

To	O
determine	O
if	O
heavy	O
resistance	I:C0872279
training	I:C0872279
in	O
hypoxia	B:C0242184
(	O
IHRT	O
)	O
is	O
more	O
effective	O
at	O
improving	O
strength	O
,	O
power	O
,	O
and	O
increasing	O
lean	O
mass	I:C0424678
than	O
the	O
same	O
training	O
in	O
normoxia	O
.	O

To	O
determine	O
if	O
heavy	O
resistance	I:C0872279
training	I:C0872279
in	O
hypoxia	O
(	O
IHRT	B:C0872279
)	O
is	O
more	O
effective	O
at	O
improving	O
strength	O
,	O
power	O
,	O
and	O
increasing	O
lean	O
mass	I:C0424678
than	O
the	O
same	O
training	O
in	O
normoxia	O
.	O

To	O
determine	O
if	O
heavy	O
resistance	I:C0872279
training	I:C0872279
in	O
hypoxia	O
(	O
IHRT	O
)	O
is	O
more	O
effective	O
at	O
improving	O
strength	O
,	O
power	B:C0424581
,	O
and	O
increasing	O
lean	O
mass	I:C0424678
than	O
the	O
same	O
training	O
in	O
normoxia	O
.	O

To	O
determine	O
if	O
heavy	O
resistance	I:C0872279
training	I:C0872279
in	O
hypoxia	O
(	O
IHRT	O
)	O
is	O
more	O
effective	O
at	O
improving	O
strength	O
,	O
power	O
,	O
and	O
increasing	O
lean	B:C0424678
mass	I:C0424678
than	O
the	O
same	O
training	O
in	O
normoxia	O
.	O

A	O
pair	O
-	O
matched	O
,	O
placebo	O
-	O
controlled	O
study	O
design	O
included	O
20	O
resistance	B:C0872279
-	I:C0872279
trained	I:C0872279
participants	O
assigned	O
to	O
IHRT	O
(	O
FIO2	O
0.143	O
)	O
or	O
placebo	O
(	O
FIO2	O
0.20	O
)	O
,	O
(	O
n	O
=	O
10	O
per	O
group	O
)	O
.	O

A	O
pair	O
-	O
matched	O
,	O
placebo	O
-	O
controlled	O
study	O
design	O
included	O
20	O
resistance	O
-	I:C0872279
trained	I:C0872279
participants	B:C0679646
assigned	O
to	O
IHRT	O
(	O
FIO2	O
0.143	O
)	O
or	O
placebo	O
(	O
FIO2	O
0.20	O
)	O
,	O
(	O
n	O
=	O
10	O
per	O
group	O
)	O
.	O

A	O
pair	O
-	O
matched	O
,	O
placebo	O
-	O
controlled	O
study	O
design	O
included	O
20	O
resistance	O
-	I:C0872279
trained	I:C0872279
participants	O
assigned	O
to	O
IHRT	B:C0872279
(	O
FIO2	O
0.143	O
)	O
or	O
placebo	O
(	O
FIO2	O
0.20	O
)	O
,	O
(	O
n	O
=	O
10	O
per	O
group	O
)	O
.	O

A	O
pair	O
-	O
matched	O
,	O
placebo	O
-	O
controlled	O
study	O
design	O
included	O
20	O
resistance	O
-	I:C0872279
trained	I:C0872279
participants	O
assigned	O
to	O
IHRT	O
(	O
FIO2	B:C2370852
0.143	O
)	O
or	O
placebo	O
(	O
FIO2	O
0.20	O
)	O
,	O
(	O
n	O
=	O
10	O
per	O
group	O
)	O
.	O

A	O
pair	O
-	O
matched	O
,	O
placebo	O
-	O
controlled	O
study	O
design	O
included	O
20	O
resistance	O
-	I:C0872279
trained	I:C0872279
participants	O
assigned	O
to	O
IHRT	O
(	O
FIO2	O
0.143	O
)	O
or	O
placebo	O
(	O
FIO2	B:C2370852
0.20	O
)	O
,	O
(	O
n	O
=	O
10	O
per	O
group	O
)	O
.	O

Participants	B:C0679646
were	O
matched	O
for	O
strength	O
and	O
training	O
.	O

Participants	O
were	O
matched	O
for	O
strength	O
and	O
training	B:C0872279
.	O

Both	O
groups	O
performed	O
20	O
sessions	O
over	O
7	O
weeks	O
either	O
with	O
IHRT	B:C0872279
or	O
placebo	O
.	O

All	O
participants	B:C0679646
were	O
tested	O
for	O
1RM	O
,	O
20	O
-	O
m	O
sprint	O
,	O
body	O
composition	O
,	O
and	O
countermovement	O
jump	O
pre	O
-	O
,	O
mid	O
-	O
,	O
and	O
post	O
-	O
training	O
and	O
compared	O
via	O
magnitude	O
-	O
based	O
inferences	O
.	O

All	O
participants	O
were	O
tested	O
for	O
1RM	O
,	O
20	O
-	O
m	O
sprint	B:C0454374
,	O
body	O
composition	O
,	O
and	O
countermovement	O
jump	O
pre	O
-	O
,	O
mid	O
-	O
,	O
and	O
post	O
-	O
training	O
and	O
compared	O
via	O
magnitude	O
-	O
based	O
inferences	O
.	O

All	O
participants	O
were	O
tested	O
for	O
1RM	O
,	O
20	O
-	O
m	O
sprint	O
,	O
body	O
composition	O
,	O
and	O
countermovement	O
jump	O
pre	O
-	O
,	O
mid	O
-	O
,	O
and	O
post	O
-	O
training	B:C0872279
and	O
compared	O
via	O
magnitude	O
-	O
based	O
inferences	O
.	O

All	O
participants	O
were	O
tested	O
for	O
1RM	O
,	O
20	O
-	O
m	O
sprint	O
,	O
body	O
composition	O
,	O
and	O
countermovement	O
jump	O
pre	O
-	O
,	O
mid	O
-	O
,	O
and	O
post	O
-	O
training	O
and	O
compared	O
via	O
magnitude	O
-	O
based	O
inferences	B:C0679201
.	O

Training	B:C0872279
improved	O
both	O
absolute	O
(	O
IHRT	O
:	O
13.1	O
±	O
3.9	O
%	O
,	O
effect	O
size	O
(	O
ES	O
)	O
0.60	O
,	O
placebo	O
9.8	O
±	O
4.7	O
%	O
,	O
ES	O
0.31	O
)	O
and	O
relative	O
1	O
RM	O
(	O
IHRT	O
:	O
13.4	O
±	O
5.1	O
%	O
,	O
ES	O
0.76	O
,	O
placebo	O
9.7	O
±	O
5.3	O
%	O
,	O
ES	O
0.48	O
)	O
at	O
mid	O
.	O

Training	O
improved	B:C0184511
both	O
absolute	O
(	O
IHRT	O
:	O
13.1	O
±	O
3.9	O
%	O
,	O
effect	O
size	O
(	O
ES	O
)	O
0.60	O
,	O
placebo	O
9.8	O
±	O
4.7	O
%	O
,	O
ES	O
0.31	O
)	O
and	O
relative	O
1	O
RM	O
(	O
IHRT	O
:	O
13.4	O
±	O
5.1	O
%	O
,	O
ES	O
0.76	O
,	O
placebo	O
9.7	O
±	O
5.3	O
%	O
,	O
ES	O
0.48	O
)	O
at	O
mid	O
.	O

Training	O
improved	O
both	O
absolute	O
(	O
IHRT	B:C0872279
:	O
13.1	O
±	O
3.9	O
%	O
,	O
effect	O
size	O
(	O
ES	O
)	O
0.60	O
,	O
placebo	O
9.8	O
±	O
4.7	O
%	O
,	O
ES	O
0.31	O
)	O
and	O
relative	O
1	O
RM	O
(	O
IHRT	O
:	O
13.4	O
±	O
5.1	O
%	O
,	O
ES	O
0.76	O
,	O
placebo	O
9.7	O
±	O
5.3	O
%	O
,	O
ES	O
0.48	O
)	O
at	O
mid	O
.	O

Training	O
improved	O
both	O
absolute	O
(	O
IHRT	O
:	O
13.1	O
±	O
3.9	O
%	O
,	O
effect	O
size	O
(	O
ES	O
)	O
0.60	O
,	O
placebo	O
9.8	O
±	O
4.7	O
%	O
,	O
ES	O
0.31	O
)	O
and	O
relative	O
1	O
RM	O
(	O
IHRT	B:C0872279
:	O
13.4	O
±	O
5.1	O
%	O
,	O
ES	O
0.76	O
,	O
placebo	O
9.7	O
±	O
5.3	O
%	O
,	O
ES	O
0.48	O
)	O
at	O
mid	O
.	O

Similarly	O
,	O
at	O
post	O
both	O
groups	O
increased	O
absolute	O
(	O
IHRT	B:C0872279
:	O
20.7	O
±	O
7.6	O
%	O
,	O
ES	O
0.74	O
,	O
placebo	O
14.1	O
±	O
6.0	O
%	O
,	O
ES	O
0.58	O
)	O
and	O
relative	O
1	O
RM	O
(	O
IHRT	O
:	O
21.6	O
±	O
8.5	O
%	O
,	O
ES	O
1.08	O
,	O
placebo	O
13.2	O
±	O
6.4	O
%	O
,	O
ES	O
0.78	O
)	O
.	O

Similarly	O
,	O
at	O
post	O
both	O
groups	O
increased	O
absolute	O
(	O
IHRT	O
:	O
20.7	O
±	O
7.6	O
%	O
,	O
ES	O
0.74	O
,	O
placebo	O
14.1	O
±	O
6.0	O
%	O
,	O
ES	O
0.58	O
)	O
and	O
relative	O
1	O
RM	O
(	O
IHRT	B:C0872279
:	O
21.6	O
±	O
8.5	O
%	O
,	O
ES	O
1.08	O
,	O
placebo	O
13.2	O
±	O
6.4	O
%	O
,	O
ES	O
0.78	O
)	O
.	O

Importantly	O
,	O
the	O
change	O
in	O
IHRT	B:C0872279
was	O
greater	O
than	O
placebo	O
at	O
mid	O
for	O
both	O
absolute	O
[	O
4.4	O
%	O
greater	O
change	O
,	O
90	O
%	O
Confidence	O
Interval	O
(	O
CI	O
)	O
1.0:8.0	O
%	O
,	O
ES	O
0.21	O
,	O
and	O
relative	O
strength	O
(	O
5.6	O
%	O
greater	O
change	O
,	O
90	O
%	O
CI	O
1.0:9.4	O
%	O
,	O
ES	O
0.31	O
(	O
relative	O
)	O
]	O
.	O

There	O
was	O
also	O
a	O
greater	O
change	O
for	O
IHRT	B:C0872279
at	O
post	O
for	O
both	O
absolute	O
(	O
7.0	O
%	O
greater	O
change	O
,	O
90	O
%	O
CI	O
1.3:13	O
%	O
,	O
ES	O
0.33	O
)	O
,	O
and	O
relative	O
1	O
RM	O
(	O
9.2	O
%	O
greater	O
change	O
,	O
90	O
%	O
CI	O
1.6:14.9	O
%	O
,	O
ES	O
0.49	O
)	O
.	O

Only	O
IHRT	B:C0872279
increased	O
countermovement	O
jump	O
peak	O
power	O
at	O
Post	O
(	O
4.9	O
%	O
,	O
ES	O
0.35	O
)	O
,	O
however	O
the	O
difference	O
between	O
IHRT	O
and	O
placebo	O
was	O
unclear	O
(	O
2.7	O
,	O
90	O
%	O
CI	O
-	O
2.0:7.6	O
%	O
,	O
ES	O
0.20	O
)	O
with	O
no	O
clear	O
differences	O
in	O
speed	O
or	O
body	O
composition	O
throughout	O
.	O

Only	O
IHRT	O
increased	O
countermovement	O
jump	O
peak	O
power	B:C0424581
at	O
Post	O
(	O
4.9	O
%	O
,	O
ES	O
0.35	O
)	O
,	O
however	O
the	O
difference	O
between	O
IHRT	O
and	O
placebo	O
was	O
unclear	O
(	O
2.7	O
,	O
90	O
%	O
CI	O
-	O
2.0:7.6	O
%	O
,	O
ES	O
0.20	O
)	O
with	O
no	O
clear	O
differences	O
in	O
speed	O
or	O
body	O
composition	O
throughout	O
.	O

Only	O
IHRT	O
increased	O
countermovement	O
jump	O
peak	O
power	O
at	O
Post	O
(	O
4.9	O
%	O
,	O
ES	O
0.35	O
)	O
,	O
however	O
the	O
difference	O
between	O
IHRT	B:C0872279
and	O
placebo	O
was	O
unclear	O
(	O
2.7	O
,	O
90	O
%	O
CI	O
-	O
2.0:7.6	O
%	O
,	O
ES	O
0.20	O
)	O
with	O
no	O
clear	O
differences	O
in	O
speed	O
or	O
body	O
composition	O
throughout	O
.	O

Heavy	B:C0872279
resistance	I:C0872279
training	I:C0872279
in	O
hypoxia	O
is	O
more	O
effective	O
than	O
placebo	O
for	O
improving	O
absolute	O
and	O
relative	O
strength	O
.	O

Heavy	O
resistance	I:C0872279
training	I:C0872279
in	O
hypoxia	B:C0242184
is	O
more	O
effective	O
than	O
placebo	O
for	O
improving	O
absolute	O
and	O
relative	O
strength	O
.	O

